Anthony J. Hinrich

675 total citations
10 papers, 497 citations indexed

About

Anthony J. Hinrich is a scholar working on Molecular Biology, Physiology and Genetics. According to data from OpenAlex, Anthony J. Hinrich has authored 10 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Physiology and 2 papers in Genetics. Recurrent topics in Anthony J. Hinrich's work include RNA modifications and cancer (2 papers), Hearing, Cochlea, Tinnitus, Genetics (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Anthony J. Hinrich is often cited by papers focused on RNA modifications and cancer (2 papers), Hearing, Cochlea, Tinnitus, Genetics (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Anthony J. Hinrich collaborates with scholars based in United States. Anthony J. Hinrich's co-authors include Michelle L. Hastings, Frank Rigo, Francine M. Jodelka, Dominik M. Duelli, Jennifer J Lentz, Nicolás G. Bazán, Hamilton E. Farris, Penelope J. Hallett, Ole Isacson and Joanna A. Korecka and has published in prestigious journals such as Nature Medicine, Scientific Reports and Human Molecular Genetics.

In The Last Decade

Anthony J. Hinrich

10 papers receiving 494 citations

Peers

Anthony J. Hinrich
Cynthia M. Gouvion United States
Graham Atkin United States
Greta Gillies Australia
Ellie M. Carrell United States
Ewa Bomba-Warczak United States
K. Verhoeven Belgium
Valerie A. Street United States
Abigail L. D. Tadenev United States
Cynthia M. Gouvion United States
Anthony J. Hinrich
Citations per year, relative to Anthony J. Hinrich Anthony J. Hinrich (= 1×) peers Cynthia M. Gouvion

Countries citing papers authored by Anthony J. Hinrich

Since Specialization
Citations

This map shows the geographic impact of Anthony J. Hinrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony J. Hinrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony J. Hinrich more than expected).

Fields of papers citing papers by Anthony J. Hinrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony J. Hinrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony J. Hinrich. The network helps show where Anthony J. Hinrich may publish in the future.

Co-authorship network of co-authors of Anthony J. Hinrich

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony J. Hinrich. A scholar is included among the top collaborators of Anthony J. Hinrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony J. Hinrich. Anthony J. Hinrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Havens, Mallory A., Anthony J. Hinrich, Frank Rigo, & Michelle L. Hastings. (2024). Elevating microRNA levels by targeting biogenesis with steric-blocking antisense oligonucleotides. RNA. 30(12). 1543–1553. 1 indexed citations
2.
Thomas, Ria, Oeystein Roed Brekk, Anthony J. Hinrich, et al.. (2023). Viral-like TLR3 induction of cytokine networks and α-synuclein are reduced by complement C3 blockade in mouse brain. Scientific Reports. 13(1). 15164–15164. 7 indexed citations
3.
Jodelka, Francine M., Anthony J. Hinrich, Tyler B. Johnson, et al.. (2020). Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease. Nature Medicine. 26(9). 1444–1451. 34 indexed citations
4.
Korecka, Joanna A., Ria Thomas, Anthony J. Hinrich, et al.. (2020). Splice-Switching Antisense Oligonucleotides Reduce LRRK2 Kinase Activity in Human LRRK2 Transgenic Mice. Molecular Therapy — Nucleic Acids. 21. 623–635. 35 indexed citations
5.
Korecka, Joanna A., Ria Thomas, Dan Ploug Christensen, et al.. (2019). Mitochondrial clearance and maturation of autophagosomes are compromised in LRRK2 G2019S familial Parkinson’s disease patient fibroblasts. Human Molecular Genetics. 28(19). 3232–3243. 51 indexed citations
6.
Korecka, Joanna A., Sébastien Talbot, Teresia Osborn, et al.. (2018). Neurite Collapse and Altered ER Ca2+ Control in Human Parkinson Disease Patient iPSC-Derived Neurons with LRRK2 G2019S Mutation. Stem Cell Reports. 12(1). 29–41. 63 indexed citations
7.
Hinrich, Anthony J., et al.. (2018). Targeting Amyloid-β Precursor Protein, APP, Splicing with Antisense Oligonucleotides Reduces Toxic Amyloid-β Production. Molecular Therapy. 26(6). 1539–1551. 41 indexed citations
8.
Hinrich, Anthony J., Francine M. Jodelka, Angela Bruno, et al.. (2016). Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides. EMBO Molecular Medicine. 8(4). 328–345. 90 indexed citations
9.
Jodelka, Francine M., Anthony J. Hinrich, Nicolás G. Bazán, et al.. (2015). Early effects of antisense oligonucleotide treatment on photoreceptor function and retinal structure in a mouse model of Usher Syndrome. Investigative Ophthalmology & Visual Science. 56(7). 5452–5452. 1 indexed citations
10.
Lentz, Jennifer J, Francine M. Jodelka, Anthony J. Hinrich, et al.. (2013). Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness. Nature Medicine. 19(3). 345–350. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026